2021 annual financial data

Xenon Pharmaceuticals Inc. 2021 Operating margin

Xenon Pharmaceuticals Inc. 2021 operating margin with verified reported values.

Direct answer

Operating margin was -428.45%.

Operating income was -78,993,000 USD and net income was -78,882,000 USD.
Operating cash flow was -69,502,000 USD.

Get free Xenon Pharmaceuticals Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
18,437,000 USD
Operating income
-78,993,000 USD
Net income
-78,882,000 USD
Operating cash flow
-69,502,000 USD